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Abstract
Muscle biopsy is an important diagnostic tool in the investigation of children with neuromuscular disorders. This report
presents the experience with paediatric muscle biopsies during a 5-year period at a routine pathology laboratory. A total
number of 58 cases were included, and indications, microscopical findings, and final histopathological diagnoses were
recorded. A total of 21 biopsies were from females (36%) and 37 biopsies from males (64%); 53% of the cases were
from children under 2 years of age. Major pathological findings were found in 30% comprising muscular dystrophy,
neurogenic atrophy, and congenital and metabolic disorders, even in cases with vague clinical manifestations. These
findings confirm the high diagnostic yield of muscle biopsies, especially as new techniques have been introduced such
as immunohistochemistry. Muscle pathology is difficult and emphasizes the importance of this service being undertaken
by specialized laboratories with an experienced staff. Microscopical examination of muscle biopsies should be based on
adequate clinical information, demonstrating the necessity of close contact between pathologists and referring
physicians.
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Introduction
Investigation of a child with suspected neuromuscu-
lar disorder is challenging, and muscle biopsy repre-
sents an important diagnostic tool. New techniques,
such as immunohistochemistry, have improved the
diagnostic value of this procedure (1 4).
Obtaining a muscle biopsy, specimen handling,
and microscopic examination are time-consuming
and resource-demanding (5). Evaluation of this
procedure with special focus on resource manage-
ment and quality assurance is therefore of great
value. Furthermore, the clinicians may have a wish
for an insight into this procedure.
The aim of this study was therefore to review and
evaluate paediatric muscle biopsies during a 5-year
period with focus on indications, histopathology,
analyses, diagnoses, and utility value.
Materials and methods
All muscle biopsies in Mid-Norway are examined at
the Department of Pathology and Medical Genetics,
St. Olavs Hospital, Trondheim University Hospital,
Trondheim, Norway. The hospital serves three
counties with a total population of about 650,000
people, of whom approximately one-fourth is under
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DOI: 10.1080/03009730802604949the age of 18. Muscle biopsies are performed both at
district general hospitals and at the university
hospital. Needle biopsy using local anaesthesia is
the preferred technique; however, sometimes an
open muscle biopsy is carried out under local or
general anaesthesia. Outside the university hospital
the specimen is kept cool on ice, transported to the
pathology department the same day, either by train
or plane. If the muscle biopsy is performed at the
university hospital, it is sent to the laboratory
immediately after removal, kept dry in a test tube.
The computer-based patient data files at the
laboratory were searched for muscle biopsies during
the time period 1998 2002. A total number of 281
biopsies were found, of which 58 cases (21%) were
from patients younger than 19 years of age. These
muscle biopsy reports were reviewed, and the
following data were recorded: age, gender, indica-
tion for biopsy, results of microscopical findings,
histochemistry, enzyme histochemistry, immunohis-
tochemistry, electron microscopy, and histopatholo-
gical diagnosis.
The muscle biopsy is prepared for light and
electron microscopy. Both paraffin and frozen sec-
tionsarecutroutinely;thelatterareespeciallysuitable
for enzyme histochemistry and immunohistochemis-
try. General histochemistry comprises haematoxylin/
eosin, Gomory trichrome (detection of ragged-red
fibresandnemalinerods),oilred(detectionoflipids),
and periodic acid-Schiff (PAS) (detection of glyco-
gen). Enzyme histochemistry demonstrates endogen-
ousenzymaticactivitiesinmusclefibresandisusedto
analyse different fibre types, detection of subcellular
organelles, structural abnormalities, and specific en-
zymatic defects. Immunohistochemistry is used for
identification of proteins and cellular elements, for
instance to characterize cells in inflammatory myo-
pathies (B cells, T cells, macrophages) and to deter-
mine fibre types, dystrophin, and dystrophin-
associated proteins. Investigation of muscular dystro-
phy sometimes requires Western blotting. Electron
microscopy is frequently performed in paediatric
muscle biopsies, especially when metabolic, mito-
chondrial, and congenital disorders are suspected,
includingnemalinemyopathy,myotubularmyopathy,
and central core disease. In difficult cases biopsies are
sent to the National Competence Centre for Muscle
Disease, University Hospital, Tromsø, Norway, for
consultation.
Results
In this series of 58 paediatric muscle biopsies no
major artefacts were observed after dispatching or
processing that might have prevented an adequate
microscopical evaluation.
Our pathology department receives annually
about 75 muscle biopsies, of which paediatric ones
comprise 10 15 specimens. The female:male ratio
was 0.6. More than half of the patients (53%) were
below 2 years of age, 17 patients (30%) between 3
and 9 years, and 10 patients (17%) in the age-group
10 18 years.
Indications for obtaining muscle biopsies were
recorded according to a modification of Heffner and
Schochet (6). Corresponding histopathological diag-
noses were listed as well. Out of 58 cases, 22 (38%)
underwent a muscle biopsy intervention due to
various muscle symptoms (pain, cramps, stiffness,
and paraesthesia), and 16 of them (73%) revealed
normal skeletal muscle or unspecific changes. The
remaining 6 cases revealed specific entities including
neurogenic atrophy (2 cases), muscular dystrophy
(not otherwise specified) (2 cases), mitochondrial
myopathy (1 case), and congenital myopathy (central
core disease) (1 case). Weakness or hypotonia were
indications in 11 out of 58 cases (19%), of which
8 cases demonstrated no pathology or unspecific
changes. In the remaining three cases congenital
disorders were detected (one congenital myopathy
and two cases with nemaline myopathy). Metabolic
disease was suspected in 10 cases (10/58, 17%); all
showed normal skeletal muscle or unspecific
changes. Questions of muscular dystrophy were
raised in 9 cases (9/58, 16%), and dystrophic changes
were seen microscopically in 4 cases (Duchenne
muscular dystrophy (3 cases) or Becker muscular
dystrophy (1 case)), mitochondrial myopathy (1
case), and neurogenic atrophy (1 case). Three cases
with elevated serum creatine kinase values displayed
no histopathological changes. In two cases with
suspected inflammatory myopathy, one disclosed
dermatomyositis and one connective tissue disease.
Normal skeletal muscle was found in about half
of the cases (28/58, 48%). Unspecific or chronic
myopathic changes, defined by Cumming et al. (7)
as atrophy, hypertrophy, internal nuclei, necrosis,
regeneration, fibrosis, and splitting, were encoun-
tered in 13 cases (22%). Four out of six cases with
dystrophic changes were found to represent Duch-
enne or Becker type due to lack of or reduced
immunostaining for dystrophin; it was not possible
to classify the two remaining cases. Neurogenic
atrophy was seen in three cases, one was Werdnig-
Hoffmann disease and one with neuroaxonal dystro-
phy. There were two cases with myositis consistent
with dermatomyositis and one case with muscular
involvement as a facet of connective tissue disorder.
Ragged-red fibres were found in two cases consistent
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to be congenital muscular disorders: nemaline myo-
pathies (2 cases), central core disease (1 case), and
one could not be classified. Table I shows cases with
major pathological findings.
Auxiliary techniques such as immunohistochem-
istry were frequently requested (74%) in order to
achieve a more distinct diagnosis, as illustrated by
lack of dystrophin expression (Figure 1). Electron
microscopy was performed in 24 out of 58 biopsies
(41%) and demonstrated important ultrastructural
pathology in 8 cases showing abnormal mitochon-
dria, deposits, or nemaline rods (Figure 2). In 23
cases (40%) the centre of competence was con-
sulted, for the most when muscular dystrophy was
suspected. In such cases extended immunohisto-
chemical analyses were performed with a
battery of antibodies against dystrophin-associated
proteins, often supplemented with protein blotting.
Sometimes genetic analyses were recommended,
especially in patients under investigation for mito-
chondrial disorders and muscular dystrophies.
Discussion
This report deals with the experience with paediatric
muscle biopsies in the daily routine at a general
pathology department during a 5-year period.
All muscle biopsies taken in Mid-Norway are
analysed at the Department of Pathology and Med-
ical Genetics, St. Olavs Hospital, Trondheim, Nor-
way, and close contact has evolved between
pathologist and referring physicians providing rele-
vant clinical information for optimal diagnostic his-
topathology. Thus, one consultant pathologist is
dedicated to this service since muscle pathology has






findings Supplementary analyses Final diagnosis
a
0 M Hypotonia Chronic myopathic
changes
Glycogen deposits (EM) Congenital myopathy possible
0 M Muscle pain, cramps,
stiffness, etc.
Neurogenic atrophy Spinal muscle atrophy
consistent with
Werdnig-Hoffmann disease
0 F Hypotonia Nemaline bodies Nemaline rods (EM) Nemaline myopathy




Myofilament pathology (EM) Central core disease
2 M Muscle pain, cramps,
stiffness, etc.
Neurogenic atrophy Neurogenic atrophy
(neuroaxonal dystrophy)
2 F Hypotonia Nemaline bodies Nemaline rods (EM) Nemaline myopathy
2 F Dermatomyositis? Chronic inflammation
and atrophy
B and T lymphocytes (IHC) Inflammatory myopathy
consistent with
dermatomyositis
2 M Muscular dystrophy? Dystrophic changes Lack of dystrophin (IHC) Duchenne muscular dystrophy
3 M Muscular dystrophy? Neurogenic atrophy Dystrophin-associated proteins
present (IHC)
Neurogenic atrophy
3 M Muscle pain, cramps,
stiffness, etc.





4 M Muscular dystrophy? Dystrophic changes Lack of dystrophin (IHC) Duchenne muscular dystrophy
5 M Muscular dystrophy? Dystrophic changes Lack of dystrophin (IHC) Duchenne muscular dystrophy
5 M Muscle pain, cramps,
stiffness, etc.





6 M Muscular dystrophy? Ragged-red fibres Abnormal mitochondria and





9 F Muscle pain, cramps,
stiffness, etc.
Ragged-red fibres Abnormal mitochondria and




10 M Muscular dystrophy? Dystrophic changes Partial lack of dystrophin (IHC,
WB)
Becker muscular dystrophy
16 F Inflammatory muscle
disease?
Necrosis Necrotizing myopathy,
probably in association with
connective tissue disease
aClassification modified after (8).
EM electron microscopy; IHC immunohistochemistry; WB Western blotting.
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centre of expertise is requisite, and several biopsies
are sent to The National Competence Centre for
MuscleDiseaseattheUniversityHospitalinTromsø,
Norway,forconsultation.Thislaboratoryisequipped
with experienced scientific and medical staff that
provides more sophisticated and extensive services
and investigations, including advanced immunohis-
tochemistrywithalargepanelof antibodies, aswellas
Western blotting and molecular genetic analyses.
Histopathological changes in muscular disorders
are often unspecific, and clinical information is the
prerequisite of making good diagnoses. In each case,
however, the pathologist should try to identify a
diagnostic category, such as normal, unspecified,
dystrophic, inflammatory, etc., since the biopsy
report serves as therapeutic guideline for the clin-
ician; even exclusion of a diagnosis is important (5).
Indication for performing muscle biopsy is in
general wide, and in the present study the most
common cause was various muscular symptoms and
signs, including pain, cramps, stiffness, paraesthesia,
weakness, and hypotonia (57%). The high number of
cases under investigation for metabolic (17%) and
hereditary disorders (including muscular dystrophy)
(17%) was not unexpected. Among the first group
normal muscle tissue or chronic myopathic changes
were found, whereas in the latter specific pathology
was recorded in 6 cases (Duchenne muscular dystro-
phy (3 cases), Becker muscular dystrophy (1 case),
neurogenic atrophy (1 case), mitochondrial myopa-
thy (1 case)). Thus, the clinical yield of muscular
biopsy is fruitful as this procedure may unveil specific
disorders despite sparse clinical manifestations.
Since several biopsies (41/58, 71%) displayed
normal skeletal muscle tissue or unspecific changes,
one may ask whether the indications are too liberal.
Performing a muscle biopsy is painful, and full
anaesthesia may be necessary. Accordingly, the phy-
sician should consider the indications for muscle
biopsy carefully. On the other hand, investigation of
children with neuromuscular disease is challenging,
and this study has clearly confirmed the clinical value
of a muscle biopsy, defending a liberal attitude to this
procedure. Needle biopsy is nowadays the preferred
method as it is less time-consuming, more cost-
effective, and encumbered with fewer complications
than an open biopsy. Disadvantages are small and
oftentraumatizedtissuesamples,althoughwedidnot
experience troublesome artefacts in this series of
muscle biopsies.
Supplementary analyses, such as immunohisto-
chemistry, histochemistry, and electron microscopy,
have resulted in identification of new pathological
structural changes (1 4,9), clearly illustrated by
ultrastructural findings in cases of congenital and
metabolic myopathies, and immunostaining in cases
of muscular dystrophies and inflammatory myopa-
thies. In this manner the utility value of a muscle
Figure 1. Muscle biopsy specimen with immunostaining for dystrophin: normal expression (left) and absence of expression in a case of
Duchenne muscular dystrophy (right).
Figure 2. Electron micrograph of nemaline rods.
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more accurate and specific diagnoses. Nevertheless,
advances in molecular genetic analyses have led to
identification of diverse gene defects. For this reason,
in patients with a family history or with a phenotype
suggesting a well characterized hereditary disorder,
available genetic tests on a blood sample or of any
other tissue should be considered (4,5).
In conclusion, muscle biopsy is invaluable in the
investigation of children with neuromuscular disor-
ders, especially by implementing auxiliary techniques
such as immunohistochemistry and electron micro-
scopy. Histopathological examination is, however,
time-consuming and requires experienced personnel,
so co-operation with a skills centre is necessary.
Further, close liaison between pathologist and clin-
icians is essential, and histopathological findings
should only be interpreted in the light of clinical
manifestations and laboratory findings. Finally, a
study like this represents a useful evaluation of this
medical procedure and is important in the quality
assurance routine of the pathology department.
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